Connect Biopharma Holdings Limited
CNTB
$2.45
-$0.23-8.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -100.00% | -66.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -100.00% | -66.67% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -100.00% | -66.67% | |||
| SG&A Expenses | -35.53% | 40.09% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.25% | 31.33% | |||
| Operating Income | 12.17% | -31.68% | |||
| Income Before Tax | 12.00% | -33.44% | |||
| Income Tax Expenses | -55.74% | 10.91% | |||
| Earnings from Continuing Operations | 12.16% | -33.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 12.16% | -33.34% | |||
| EBIT | 12.17% | -31.68% | |||
| EBITDA | 12.30% | -32.03% | |||
| EPS Basic | 12.70% | -32.83% | |||
| Normalized Basic EPS | 12.58% | -32.99% | |||
| EPS Diluted | 12.70% | -32.83% | |||
| Normalized Diluted EPS | 12.58% | -32.99% | |||
| Average Basic Shares Outstanding | 0.64% | 0.39% | |||
| Average Diluted Shares Outstanding | 0.64% | 0.39% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||